WillItSurvive
Food tech and alternative protein · subsidiary of Mitsui & Co., Ltd. (80% ownership); Nippon Soda Co., Ltd. (20% ownership) · United States

Novus International

novusint.com ↗

Novus makes methionine and other feed additives that livestock producers add to animal feed.

Hard to displace
Assessed 25 July 2026 · Evidence as of 25 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 25 July 2026 · Checkable from March 2026 · Every call on the record Checkpoint: Novus, Inc. v. USA trade litigation ruling, plus outcome of the 2025 methionine/specialty P&L split
The call

Novus sits inside a small, capital-heavy oligopoly making a chemical animals need to grow, protected more by plants and permits than by any technology edge.

Novus International makes methionine, a chemical ingredient that goes into animal feed to help livestock grow. The company is hard to replace because it costs hundreds of millions of dollars to build a factory that makes this product, and governments regulate who can sell it, which keeps smaller competitors out. The big rival companies Adisseo, Evonik, and DSM-Firmenich could try to take market share, but building new factories takes years. The one thing that could change everything is the company's June 2025 decision to split itself into two separate business units, which looks like preparation to sell one of those units to a buyer, and which unit gets sold will decide whether Novus stays as strong as it is today.

Why
01
AI pressure: None apparent. AI feed-optimization software could trim how much methionine farms buy per animal, but no product does this at scale yet. Could AI do the core job? Unlikely.
02
Bigger players: Adisseo, Evonik Industries, DSM-Firmenich. These chemical and nutrition giants already sell competing methionine and additive lines into the same global feed market. Could a giant copy it? No, they are blocked.
03
What protects it. A ~30% global methionine share, decades of regulatory approvals, and capital-heavy plants that take years and huge sums to replicate.
What would change this call
Announcement of a sale or spin-off of the methionine unit following the June 2025 P&L split. Would show Mitsui/Nippon Soda are exiting or reshaping the commodity business.
Public confirmation of Novus's current CEO (Fraudeau vs. Meagher) in company or trade press. Would clarify leadership stability during the restructuring period.
Methionine spot price trends reported by industry trade press (e.g. ICIS, Feedinfo) through 2026. Sustained price collapse would test parent patience and margin durability.
Key numbers
  • Founded 1991 from Monsanto's methionine business (1991)
  • ~30% global methionine market share (2015)
  • Operates in 90+ countries (2026-07-04)
Named risks
  • June 2025 P&L split into methionine and specialty units may precede a divestiture of one segment. Severity: medium
  • EPA HON Rule compliance deadlines (2026-2028) could raise costs at Gulf Coast Texas and Louisiana plants. Severity: medium
  • Conflicting public reporting on current CEO identity (Fraudeau vs Meagher) signals leadership clarity gap. Severity: low
  • Methionine commodity price cyclicality could pressure margins against larger rivals Evonik and Adisseo. Severity: medium
  • March 2026 trade litigation naming 'Novus, Inc.' has unconfirmed entity linkage but could involve tariff exposure. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Evonik Industrieslosing toReported larger than Novus in methionine, per March 2026 pricing report
Adisseolosing toReported larger than Novus in methionine, per March 2026 pricing report
DSM-Firmenichlosing toHolds ~30% of broader global animal nutritional ingredients market, 2023 report
Kemin IndustriescontestingNamed peer specialty animal nutrition competitor in 2023 market report
AlltechcontestingNamed peer specialty animal nutrition competitor in 2023 market report
Zinpro CorporationcontestingNamed peer specialty animal nutrition competitor in 2023 market report
Questions people ask
Who owns Novus International?
Novus International has been privately owned by Mitsui & Co. and Nippon Soda since its 1991 formation from Monsanto's methionine business. Mitsui raised its stake from 65% to 80% in May 2016, with Nippon Soda holding the remaining 20%, per Mitsui's own release.
Is Novus International profitable?
Novus does not publicly disclose financials as a private subsidiary, so profitability cannot be confirmed from filings. It has operated continuously since 1991 under the same two strategic owners with no reported distress, acquisitions (BioResource International, March 2024), and a June 2025 restructuring signal ongoing investment.
Could AI replace Novus International's core business?
Unlikely for its core business. Novus manufactures physical feed-additive chemistry (methionine, enzymes) requiring plants and regulatory approvals. AI (precision livestock farming tools) mainly threatens its peripheral advisory/consulting layer, not manufacturing, as of 2025 research.
Who is Novus International's biggest competitor?
Evonik Industries and Adisseo are reported as larger than Novus in methionine specifically as of March 2026, while DSM-Firmenich is the largest incumbent in broader animal nutritional ingredients, alongside peers Kemin, Alltech, and Zinpro.
Is Novus International publicly traded?
No. Novus International is privately held, formed in 1991 when Mitsui & Co. and Nippon Soda jointly acquired Monsanto's methionine business. There is no evidence of an IPO or private-equity buyout; Mitsui held 80% and Nippon Soda 20% as of May 2016.
Has Novus International had layoffs?
No public layoff announcements were found. The company underwent a strategic business realignment in June 2025, splitting into liquid methionine and specialty ingredients units, but no confirmed workforce reduction news accompanied this move.
Timeline
  • 2026-03Trade litigation 'Novus, Inc. v. United States' filed in Court of International Trade; entity link unconfirmed
  • 2025-10Ed Galo named head of Methionine business, Ryan Shirley head of Specialty business
  • 2025-06Novus splits into two independent P&L units: liquid methionine and specialty feed ingredients
  • 2024-03Novus completes acquisition of enzyme company BioResource International (partner since 2008)
  • 2023-06Company-wide rebrand around 'intelligent nutrition' unveiled at World Pork Expo
  • 2016-05Mitsui increases Novus stake from 65% to 80%; Nippon Soda reduced to 20%
  • 1991Novus formed when Mitsui and Nippon Soda jointly acquired Monsanto's methionine business
Revision history
25 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Toyo Suisan Kaisha, Ltd.IOI Corporation BerhadBunge Global
More in Food tech and alternative protein →
Sources